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Background
Although transgenic animal models of Alzheimer’sd i s -
ease (AD) have proven to be relatively faithful models
for neuropathological changes, none completely recapi-
tulate the disease process. We aimed to establish new
AD transgenic models with senescence accelerated
mouse prone 8 (SAMP8) background.
Method
In the experiments, APP/PS1 and tau
P301L transgenic
mice of C57BL/6J background were interbred with
SAMP8 mice for five generations. Gene identification of
filial generation was tested by PCR. The grading score
system developed by Takeda T et al was used for eva-
luation of the degree of senescence in mice. The age-
related decline of learning and memory ability was ana-
lyzed using passive avoidance shuttle box and Morris
water maze tasks. Immunofluorescence study was per-
formed to ascertain the presence of b-amyloid (Ab)a n d
tau pathology in AD mouse models by using b-amyloid
antibody and specific phosphorylated tau antibody at
Ser404.
Results
Both APP/PS1 and tau
P301L transgenic mice in SAMP8
background exhibited accelerated aging with a high
grading score. The transgenic mice with SAMP8 back-
ground also exhibited age-dependent cognitive impair-
ments, compared with transgenic mice with C57BL/6J
background or wild mice with SAMP8 background at
t h es a m ea g e .I ns h u t t l eb o xa v o i d a n c et a s k ,t a u
P301L
transgenic mice with SAMP8 background had obvious
memory deficit very early in life, approximately at the
age of 6-month old. Probe trial in Morris water maze
test showed a marked deficit in the APP/PS1 transgenic
mice with SAMP8 background, which spent less time at
platform quadrant, compared with APP/PS1 transgenic
mice with C57BL/6J background or wild mice with
SAMP8 background at the same age of 9-month old. In
immunohistochemistry studies, SAMP8 mice showed
sporadic Ab deposition in the hippocampus, cortex and
thalamus from as early as 6-month old, and increase in
number and extent with age. Significant elevation of Ab
deposition in the whole brain, even extent to the cere-
bellum and spinal cord of 6–month-old APP/PS1 trans-
genic mice with SAMP8 background could be seen. We
also found that obvious immunofluorescent staining of
phosphorylates tau at Ser404 (PHF-tau) in the hippo-
campus, cortex and thalamus 9-month-old tau
P301L
transgenic with SAMP8 background. However, no
obvious phosphorylated tau were found in wild SAMP8
mice or tau
P301L transgenic C57BL/6J mice even at the
age of 9 months, when compared with wild C57BL/6J
mice.
Conclusion
The characterized neuropathological alterations and
cognitive impairment in AD can be reproduced geneti-
cally early in transgenic mice over-expressing APP/PS1
or tau
P301L genes with senescence accelerated back-
ground. These novel mouse models for AD will help to
clarify the pathogenic mechanism and allow assessment
of the effects of new treatment strategies.
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